G Todd Alonso1, Laura Pyle2, Brigitte Frohnert3. 1. Department of Pediatrics, University of Colorado School of Medicine, United States; The Barbara Davis Center for Childhood Diabetes, Aurora, CO, United States. Electronic address: guy.alonso@ucdenver.edu. 2. Department of Biostatistics and Informatics, Colorado School of Public Health, United States. 3. Department of Pediatrics, University of Colorado School of Medicine, United States; The Barbara Davis Center for Childhood Diabetes, Aurora, CO, United States.
Abstract
AIMS: In June 2014, the American Diabetes Association lowered recommended hemoglobin A1c (HbA1c) targets from <8.5% (69mmol/mol) for children <6years of age and from <8.0% (64mmol/mol) for children 6-12years of age to <7.5% (58mmol/mol). Lower target HbA1c may lead to better glycemic control but could increase the risk of severe hypoglycemia. METHODS: Patients with type 1 diabetes >1year duration, age 0-12years and seen in our center between January 1 and June 30, 2014 or between January 1 and June 30, 2015 were included. 1013 unique patients had 2684 encounters. We analyzed first quarterly HbA1c (January-March, April-June) and self-reported severe hypoglycemia at all clinic encounters. RESULTS: HbA1c across the age span and within the 0-<6, 6-12, and 0-12year old groups did not differ in the insurance adjusted mixed-effects model. Least squares means for all patients' HbA1c in 2014 was 8.59±0.04 (70±0.5mmol/mol); for 2015, 8.60±0.04 (70±0.5mmol/mol) (p=0.90). Severe hypoglycemia data fields were more complete in 2015 (43% vs 50%). Logistic regression adjusting for follow up showed no difference in severe hypoglycemia for all ages (p=0.80). CONCLUSIONS: HbA1c did not change 1year after the updated guidelines despite adoption of the new targets. Assessing changes in severe hypoglycemia may require larger, prospective datasets or longer observation.
AIMS: In June 2014, the American Diabetes Association lowered recommended hemoglobin A1c (HbA1c) targets from <8.5% (69mmol/mol) for children <6years of age and from <8.0% (64mmol/mol) for children 6-12years of age to <7.5% (58mmol/mol). Lower target HbA1c may lead to better glycemic control but could increase the risk of severe hypoglycemia. METHODS:Patients with type 1 diabetes >1year duration, age 0-12years and seen in our center between January 1 and June 30, 2014 or between January 1 and June 30, 2015 were included. 1013 unique patients had 2684 encounters. We analyzed first quarterly HbA1c (January-March, April-June) and self-reported severe hypoglycemia at all clinic encounters. RESULTS: HbA1c across the age span and within the 0-<6, 6-12, and 0-12year old groups did not differ in the insurance adjusted mixed-effects model. Least squares means for all patients' HbA1c in 2014 was 8.59±0.04 (70±0.5mmol/mol); for 2015, 8.60±0.04 (70±0.5mmol/mol) (p=0.90). Severe hypoglycemia data fields were more complete in 2015 (43% vs 50%). Logistic regression adjusting for follow up showed no difference in severe hypoglycemia for all ages (p=0.80). CONCLUSIONS: HbA1c did not change 1year after the updated guidelines despite adoption of the new targets. Assessing changes in severe hypoglycemia may require larger, prospective datasets or longer observation.
Authors: Janet Silverstein; Georgeanna Klingensmith; Kenneth Copeland; Leslie Plotnick; Francine Kaufman; Lori Laffel; Larry Deeb; Margaret Grey; Barbara Anderson; Lea Ann Holzmeister; Nathaniel Clark Journal: Diabetes Care Date: 2005-01 Impact factor: 19.112
Authors: Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane Journal: Diabetes Care Date: 2015-06 Impact factor: 19.112
Authors: Richard M Bergenstal; William V Tamborlane; Andrew Ahmann; John B Buse; George Dailey; Stephen N Davis; Carol Joyce; Tim Peoples; Bruce A Perkins; John B Welsh; Steven M Willi; Michael A Wood Journal: N Engl J Med Date: 2010-06-29 Impact factor: 91.245
Authors: David M Maahs; Julia M Hermann; Stephanie N DuBose; Kellee M Miller; Bettina Heidtmann; Linda A DiMeglio; Birgit Rami-Merhar; Roy W Beck; Edith Schober; William V Tamborlane; Thomas M Kapellen; Reinhard W Holl Journal: Diabetologia Date: 2014-06-04 Impact factor: 10.122
Authors: William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing Journal: N Engl J Med Date: 2008-09-08 Impact factor: 91.245
Authors: Scott A Clements; Matthew D Anger; Franziska K Bishop; Kim K McFann; Georgeanna J Klingensmith; David M Maahs; R Paul Wadwa Journal: Int J Pediatr Endocrinol Date: 2013-10-24